Back

Human Induced Pluripotent Stem Cells-derived cells for drug testing

14 June 2026 (14:05 - 14:30)
Organised by: Logo
Seminar Presentation Part of: Module E: industrial applications - Advanced models of drug testing for cardiac diseases Drugs, Drug Targets Open Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Professor Katrin Streckfuss-Boemeke

University Hospital Wuerzburg, Wuerzburg (Germany)

2 More presentations in this session

Presentation thumbnail
Organ-on-a-chip and microfluidic systems
Professor L. Maegdefessel (Munich, DE)
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
Module E: industrial applications - Advanced models of drug testing for cardiac diseases

The Event

Event poster

Basic Science Course 2026

14 June 2026 14:05 CET
You may be interested in
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025
thumbnail
Congress Presentation
Stiffness-driven electrical remodeling: exploring mechanosensitive dynamics in hiPSC-CM
30 March 2025
thumbnail
Congress Presentation
Automated patch-clamp of human induced pluripotent stem cell (hiPSC) derived atrial cardiomyocytes as a promising technique to determine the electrophysiological impact of genetic risk variants
29 August 2025
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources